1. First-in-human trial of the safety, pharmacokinetics and immunogenicity of a PEGylated anti-CD40L antibody fragment (CDP7657) in healthy individuals and patients with systemic lupus erythematosus. (September 2015) Authors: Tocoian, A; Buchan, P; Kirby, H; Soranson, J; Zamacona, M; Walley, R; Mitchell, N; Esfandiari, E; Wagner, F; Oliver, R Journal: Lupus Issue: Volume 24:Number 10(2015) Page Start: 1045 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗